The agency sent letters to six pharmaceutical makers of the products on Jan. 19 detailing the safety related labeling changes. The drugmakers must now include boxed warnings stating “T cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback